These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16434340)

  • 21. Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005.
    Dobardzic A; Izurieta H; Woo EJ; Iskander J; Shadomy S; Rupprecht C; Ball R; Braun MM
    Vaccine; 2007 May; 25(21):4244-51. PubMed ID: 17382435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosphenytoin and status epilepticus.
    Brown J
    Hosp Med; 1999 Jan; 60(1):70-1. PubMed ID: 10197108
    [No Abstract]   [Full Text] [Related]  

  • 23. The safety of niacin in the US Food and Drug Administration adverse event reporting database.
    Alsheikh-Ali AA; Karas RH
    Am J Cardiol; 2008 Apr; 101(8A):9B-13B. PubMed ID: 18375244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System.
    Chan-Tack KM; Truffa MM; Struble KA; Birnkrant DB
    AIDS; 2007 May; 21(9):1215-8. PubMed ID: 17502736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fosphenytoin sodium: new drug to replace intravenous phenytoin sodium.
    Voytko SM; Farrington E
    Pediatr Nurs; 1997; 23(5):503-6. PubMed ID: 9355589
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin.
    Coplin WM; Rhoney DH; Rebuck JA; Clements EA; Cochran MS; O'Neil BJ
    Neurol Res; 2002 Dec; 24(8):842-8. PubMed ID: 12500711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.
    Cope JU; Morrison AE; Samuels-Reid J
    Pediatrics; 2008 May; 121(5):e1133-8. PubMed ID: 18450857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atrioventricular junctional arrhythmia due to oral phenytoin intoxication].
    Magadle R; Weiner P; Waizman J
    Harefuah; 1999 Mar; 136(6):446-8, 514. PubMed ID: 10914260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin.
    Ramsay RE; Wilder BJ; Uthman BM; Garnett WR; Pellock JM; Barkley GL; Leppik IE; Knapp LE
    Epilepsy Res; 1997 Oct; 28(3):181-7. PubMed ID: 9332883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intramuscular midazolam in the initial treatment of status epilepticus].
    Galdames-Contreras D; Carrasco-Poblete E; Aguilera-Olivares L; Fabres-Oyarzo L; Galdames-Poblete D
    Rev Neurol; 2006 Mar 16-31; 42(6):332-5. PubMed ID: 16575768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Purple hand syndrome and intravenous phenytoine].
    Schmutz J; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 May; 127(5):548. PubMed ID: 10863194
    [No Abstract]   [Full Text] [Related]  

  • 32. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus.
    Uges JW; van Huizen MD; Engelsman J; Wilms EB; Touw DJ; Peeters E; Vecht CJ
    Epilepsia; 2009 Mar; 50(3):415-21. PubMed ID: 19054418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fosphenytoin-induced purple glove syndrome: A case report.
    Newman JW; Blunck JR; Fields RK; Croom JE
    Clin Neurol Neurosurg; 2017 Sep; 160():50-53. PubMed ID: 28648954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with fosphenytoin in children.
    Morton LD
    J Child Neurol; 1998 Oct; 13 Suppl 1():S19-22; discussion S30-2. PubMed ID: 9796748
    [No Abstract]   [Full Text] [Related]  

  • 36. Fosphenytoin.
    Luer MS
    Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007.
    Gubernot DM; Lucey CT; Lee KC; Conley GB; Holness LG; Wise RP
    Clin Infect Dis; 2009 Jan; 48(1):25-30. PubMed ID: 19035776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fosphenytoin use in children.
    Pellock JM
    Neurology; 1996 Jun; 46(6 Suppl 1):S14-6. PubMed ID: 8649608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status epilepticus in central nervous system infections: an experience from a developing country.
    Misra UK; Kalita J; Nair PP
    Am J Med; 2008 Jul; 121(7):618-23. PubMed ID: 18589058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.